Immune checkpoint inhibitor-associated arthritis in advanced pulmonary adenocarcinoma: A case report

BACKGROUND: With the wide application of immune checkpoint inhibitors (ICIs) in cancer treatment, immune-related adverse events occur frequently, involving almost all organs and systems. The incidence of ICI-associated arthritis (IA) is unknown. In most cases, IA is not serious and non-lethal. Highe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yan, Huang, Xiao-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602251/
https://www.ncbi.nlm.nih.gov/pubmed/36312471
http://dx.doi.org/10.12998/wjcc.v10.i29.10701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602251/
https://www.ncbi.nlm.nih.gov/pubmed/36312471
http://dx.doi.org/10.12998/wjcc.v10.i29.10701

Ejemplares similares